Dow Jones

39,908.00

0.88%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

GLPG

Galapagos (GLPG)

Galapagos

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:GLPG

1 2 3 4 5 6 7 8 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
22/02/2024	15:01	UK Regulatory	Galapagos announces full year 2023 results and outlook for 2024	LSE:GLPG	Galapagos
15/02/2024	15:01	UK Regulatory	Galapagos presents at EBMT-EHA annual meeting 2024	LSE:GLPG	Galapagos
31/01/2024	15:01	UK Regulatory	Galapagos completes transaction to transfer Jyseleca® business to Alfasigma	LSE:GLPG	Galapagos
06/05/2015	00:31	GlobeNewswire	Galapagos listed 10 years on Euronext Amsterdam and Brussels	LSE:GLPG	Galapagos
06/05/2015	00:31	GlobeNewswire	Galapagos announces launch of proposed global offering	LSE:GLPG	Galapagos
01/05/2015	11:00	GlobeNewswire	BNP Paribas notify of 4.8% shareholding in Galapagos	LSE:GLPG	Galapagos
01/05/2015	11:00	GlobeNewswire	Galapagos creates new warrant plan	LSE:GLPG	Galapagos
27/04/2015	15:00	GlobeNewswire	Filgotinib as monotherapy also hits primary endpoint in DARWIN 2 trial	LSE:GLPG	Galapagos
15/04/2015	16:00	GlobeNewswire	Galapagos files registration statement in the United States for a proposed global offering	LSE:GLPG	Galapagos
14/04/2015	15:00	GlobeNewswire	Galapagos' JAK1 inhibitor filgotinib (GLPG0634) meets primary and other key efficacy endpoints after 12 weeks of treatment in...	LSE:GLPG	Galapagos
27/03/2015	13:29	GlobeNewswire	Publication of Annual Report 2014 and invitation to the Annual Shareholders' Meeting to be held on 28 April 2015	LSE:GLPG	Galapagos
27/03/2015	01:30	GlobeNewswire	Galapagos raises €5.8 million through warrant exercises, Board and Executive Committee members invest	LSE:GLPG	Galapagos
17/03/2015	01:31	GlobeNewswire	Galapagos regains rights to GLPG1690, announces end of alliance with Janssen	LSE:GLPG	Galapagos
06/03/2015	00:35	GlobeNewswire	Galapagos to be included in Amsterdam Midcap Index	LSE:GLPG	Galapagos
06/03/2015	00:31	GlobeNewswire	Galapagos reports 2014 financial results	LSE:GLPG	Galapagos
23/02/2015	00:30	GlobeNewswire	Galapagos reports that the last patient in DARWIN 1 has completed 12 weeks of treatment	LSE:GLPG	Galapagos
16/02/2015	00:30	GlobeNewswire	Galapagos reports positive Phase 1 results for GLPG1690	LSE:GLPG	Galapagos
11/02/2015	00:31	GlobeNewswire	Galapagos receives €1.6 million IWT grant for hepatitis B program	LSE:GLPG	Galapagos
09/02/2015	00:31	GlobeNewswire	BNP Paribas notify of 5.08% shareholding in Galapagos	LSE:GLPG	Galapagos
22/01/2015	00:31	GlobeNewswire	Galapagos receives €2.5 million IWT grant for antibiotic research	LSE:GLPG	Galapagos
21/01/2015	11:56	GlobeNewswire	Delta Lloyd notify of 4.96% shareholding in Galapagos	LSE:GLPG	Galapagos
09/01/2015	00:30	GlobeNewswire	Vicki Sato resigns from Galapagos Board	LSE:GLPG	Galapagos
08/01/2015	00:30	GlobeNewswire	Galapagos starts Phase 2 trial with GLPG1205 in ulcerative colitis patients	LSE:GLPG	Galapagos
19/12/2014	00:31	GlobeNewswire	Galapagos initiates first Phase 1 study in cystic fibrosis and will receive milestone payment from AbbVie	LSE:GLPG	Galapagos
16/12/2014	00:32	GlobeNewswire	Galapagos regains full rights to GPR84 inhibitor GLPG1205	LSE:GLPG	Galapagos
12/12/2014	00:31	GlobeNewswire	Galapagos selects second component of its investigational cystic fibrosis combination treatment	LSE:GLPG	Galapagos
08/08/2014	00:30	GlobeNewswire	Galapagos cash position of €232 M provides solid basis for R&D pipeline investment	LSE:GLPG	Galapagos
05/08/2014	00:31	GlobeNewswire	Galapagos receives milestone in osteoarthritis alliance with Servier	LSE:GLPG	Galapagos
23/07/2014	00:30	GlobeNewswire	MorphoSys and Galapagos Advance Joint Antibody Program in Inflammatory Diseases into Preclinical Development	LSE:GLPG	Galapagos
04/07/2014	11:00	GlobeNewswire	Galapagos raises €1.9 million through warrant exercises	LSE:GLPG	Galapagos